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IntroductIon
The actin cytoskeleton is crucial for normal immune func-
tion, and a growing number of primary immunodeficiencies 
are caused by mutations in actin-regulating genes (Moulding 
et al., 2013). Autoinflammatory diseases (AIDs) are defined as 
diseases predominantly of the innate immune system resulting 
in abnormally increased inflammation (Standing et al., 2013), 
and it is recognized that autoinflammation and immunodefi-
ciency may coexist (Frenkel, 2014). Recently, a new AID has 
been described in mice (WDR1rd/rd mouse), caused by reces-
sive mutation in WDR1 (Kile et al., 2007; Kim et al., 2015), 
a WD40 repeat protein that interacts with cofilin to promote 
F-actin severing and depolymerization (Okada et al., 1999, 
2002; Rodal et al., 1999; Ono et al., 2004). Autoinflammation 
in the WDR1rd/rd mouse is caused by excessive IL-18 pro-
duction by monocytes, and not by IL-1β. This dysregulated 
monocytic IL-18 secretion requires caspase-1, apoptosis-as-
sociated speck-like protein containing a caspase recruitment 
domain (ASC), and pyrin (Kim et al., 2015). In this study, we 
have identified a family with severe autoinflammatory disease 
with many features in common with the murine disease, and 
harboring a variant in WDR1.
results and dIscussIon
Two Pakistani girls (patients IV-2 and IV-4; Fig. 1 A) born 
of consanguineous parents suffered from a severe AID begin-
ning in the first weeks of life. Both had periodic fevers lasting 
3–7 d, every 6–12 wk, with severe acute phase responses: C- 
reactive protein, >270 mg/liter (reference range [RR] < 20); 
serum Amyloid A, >200 mg/liter (RR < 10); leukocytosis, 32 
× 109/liter (predominantly neutrophils); hyperferritinaemia, 
82–2,679 µg/ml (RR 11–76); and thrombocytopenia, 24–90 
× 109/liter; as well as normalization of these parameters in 
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between fever attacks. Both had severe recurrent oral inflam-
mation, which caused scarring and acquired microstomia in 
patient IV-2 (Fig.  1  B), and recurrent perianal ulceration. 
Genetic screening for common AIDs (TNF RSF1A, MVK, 
NLRP3, and MEFV) was negative. Frequent infections were 
also observed even before immunosuppression. Patient IV-4 
developed Pneumocystis jiroveci pneumonia at 5 mo of age; 
and Staphylococcus aureus septic arthritis of the knee at 2 yr of 
age. Patient IV-2 developed Streptococcus pneumonia nec-
rotizing cellulitis 13 yr of age (Fig.  1  C). Both developed 
severe inflammatory responses to (presumed) viral infec-
tions, with moderate thrombocytopenia. Mean platelet vol-
ume (MPV) was elevated in patient IV-2, but within normal 
range for IV-4 (Fig. 1 D). Bone marrow aspirate in patient 
IV-4 revealed ultrastructural abnormalities of megakaryocytes 
by electron microscopy (Fig. 1 E). Detailed immunological 
work-up of both children excluded autoimmunity, com-
mon primary immunodeficiency syndromes, and primary 
hemophagocytic lymphohistiocytosis (Table S1). In patient 
IV-4, phytohemagglutinin (PHA) stimulation of T cells was 
normal, but T cell activation in response to stimulation with 
anti-CD3 was diminished, implicating a defect in adaptive 
immunity. Patient IV-2 had normal T cell activation to PHA, 
but T cell activation in response to anti-CD3 was not doc-
umented. Neutrophil respiratory burst and phagocytosis of 
opsonized Escherichia coli (in IV-4) were normal.
Figure 1. clinical features and results of genetic analyses in the family. The family pedigree (A) shows the two affected female siblings, and their two 
unaffected siblings from consanguineous marriage of double first cousins; segregation of the c.877C>T WDR1 variant is also shown. Acquired microstomia 
(B) in patient IV-2 aged 12 yr and 10 mo, the consequence of recurrent sterile oral inflammatory episodes. At 13 yr of age, patient IV-2 developed a severe 
necrotizing cellulitis of the neck caused by Streptococcus pneumoniae (C). (D) Mean platelet volume (fl) derived from a standard complete blood count using 
a Beckman Coulter counter. Normal reference range (7.8–11 fl) is denoted by the gray shaded area. Data are 20 random measurements taken as routine 
clinical care; horizontal lines denote mean and SEM. Patient IV-2 had mean MPV consistently greater than the reference range (with the exception of two 
measurements: mean MPV, 11.77 fl; range, 10.6–13.10), and significantly higher than her sibling both before and after HSCT (P < 0.0001, ANO VA). Patient 
IV-4 had MPV consistently within normal range (mean, 9.58 fl; range, 8.50–11.00). However, MPV was significantly lower after HSCT (P = 0.0091, nonpaired 
Student’s t test). Transmission electron microscopy of megakaryocytes in a bone marrow aspirate before allogeneic HSCT in patient IV-4 (E) revealed oc-
casional small, atypical megakaryocytes with no nucleus and failure of the demarcating membrane system to develop resulting in a large peripheral zone 
(arrows) devoid of organelles and granules. Developing platelets were located in the central area of the cell.
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Both children partially responded to corticosteroids, and 
to colchicine, but poor growth and inflammatory attacks per-
sisted. Patient IV-2 failed several antiinflammatory and im-
munosuppressive agents (Table S1). There was, however, some 
transient steroid sparing effect in response to anakinra (2–4 
mg/kg s.c. daily). Ultimately, however, this did not control 
the episodes of autoinflammation, and this patient died at 14 
yr of age from sterile systemic inflammation and multiorgan 
failure. Patient IV-4 successfully underwent allogeneic hema-
topoietic stem cell transplantation (HSCT) at age 8, and re-
mains well, off all medication, 3 yr later.
We used exome sequencing combined with homo-
zygosity mapping to investigate the genetic cause. Regions 
of homozygosity are provided in Table S2. We confirmed 
that there were no further variants of interest in any known 
autoinflammatory genes in the INF EVE RS database (Sar-
rauste de Menthière et al., 2003) or HLH genes (Bode et al., 
2012), including NLRC4 (Canna et al., 2014), nor in genes 
that could generate increased IgA levels, such as CD40L or 
NEMO (Allen et al., 1993; Orange et al., 2004). On chromo-
some 4, a homozygous mutation was identified in WDR1 
through exome sequencing, which has not been reported in 
dbSNP or the exome sequencing project databases. This mis-
sense mutation affects both transcripts of the gene: transcript 
1 exon 8 c.877C>T, amino acid change L293F and transcript 
2 exon 5 c.457C>T, amino acid change L153F are predicted 
to be damaging by PolyPhen2 (Adzhubei et al., 2010) and 
MutationTaster (Schwarz et al., 2010) and segregated with 
disease (Fig. 1 A). The protein comprises 14 WD40 repeats, 
which are organized into two propellers with seven blades 
each (Fig. 2 A; Mohri et al., 2004). The mutation is predicted 
to disrupt intramolecular hydrophobic interactions, which are 
important for maintaining protein structure (Fig. 2, B–E).
The cofilin–WDR1 complex facilitates breakdown of 
existing filaments while promoting increased F-actin po-
lymerization from newly created barbed ends, and is thus 
pivotal in the maintenance of cytoskeletal integrity and 
function (Rodal et al., 1999). In the WDR1rd/rd mouse, neu-
trophils and macrophages showed increased levels of polym-
erized actin compared with wild-type. Phalloidin staining 
and flow cytometry of monocyte-derived DCs (moDCs), 
CD14− lymphocytes, and Epstein-Barr virus (EBV)–trans-
formed lymphoblasts from IV-4 demonstrated increased 
levels of polymerized F-actin relative to control (Fig. 3 A). 
Confocal microscopy confirmed more intense F-actin–rich 
podosome staining and abnormal intracellular aggregates of 
WDR1 in patient moDCs (Fig.  3 B). Although the num-
ber of podosomes was similar, the volume of patient IV-4’s 
podosomes was greater than control (Fig. 3 C). Podosomes 
are cellular adhesion structures involved in matrix degra-
dation and invasion, containing an F-actin core and a ring 
of cytoskeletal adaptor proteins, including WDR1 (Cervero 
et al., 2012). Increased podosome volumes observed here 
are consistent with diminished F-actin depolymerization 
caused by defective WDR1.
In an attempt to model this, we transduced the THP1 
monocytic cell line with shRNA against WDR1 or with a 
scrambled control. We produced two cell lines with different 
shRNA sequences that showed negligible WDR1 expression 
compared with untransduced cells and scrambled control. 
However, these cells showed no difference in actin polymer-
ization assessed by flow cytometry (Fig. S2 F). This phenome-
non has been reported previously; depleted WDR1 levels may 
lead to up-regulation of caspase 11 and cofilin, to partially 
rescue the defect (Li et al., 2007; Okreglak and Drubin, 2007). 
Furthermore, In the WDR1rd/rd mouse the protein is also 
misfolded (Kile et al., 2007), thus mutant rather than absent 
WDR1 is likely required for the autoinflammatory phenotype.
Autoinflammation in the WDR1rd/rd mouse is driven by 
IL-18 independently of IL-1β. IL-1β and IL-18 are activated 
by inflammasomes, and have both overlapping and divergent 
roles (Brydges et al., 2013). Sera from both patients taken at 
three to five time points over 5–7 mo (preHSCT) demon-
strated no change in IL-1β compared with healthy childhood 
controls (Fig. 4 A), but did have elevated IL-18 levels, which 
were higher than levels detected in systemic juvenile idiopathic 
arthritis (sJIA) patients (Fig. 4 B; Chen et al., 2013). In contrast 
to the sJIA patients, however, levels of IL-18–binding protein 
(IL-18BP) were not elevated (Fig. 4 C). IL-18BP neutralizes 
the proinflammatory activity of IL-18, thus the low levels ob-
served may contribute to the autoinflammatory phenotype 
(Chen et al., 2013; Dinarello et al., 2013). IL-18 levels mirrored 
SAA and C-reactive protein (CRP) levels in IV-2, who was on 
anakinra when samples were taken (Fig. 4 D), and were per-
sistently elevated in IV-4 (not on anakinra; Fig. 4 E). Although 
there was partial efficacy of anakinra in IV-2 that could suggest 
a role for IL-1β in the human disease, we are intrigued by 
recent suggestions that anakinra may also partially antagonize 
IL-18 (Brydges et al., 2013; Vastert et al., 2014). IL-1β levels 
are usually low in serum, even in IL-1β–mediated diseases, as 
it often acts locally and degrades rapidly. Therefore we also 
investigated IL-1β and IL-18 production from the cultured 
moDCs treated with LPS for 4 h. We detected elevated IL-18 
production, but not IL-1β, from patient cells (Fig. 4, G and H) 
in response to LPS. As before, polymerized F-actin levels were 
assessed using flow cytometry. Untreated moDCs from patient 
IV-4 had 1.3-fold F-actin intensity versus control, rising to 
1.8-fold after LPS treatment (Fig. 4 I). We also detected signifi-
cantly increased IL-18 production from cultured neutrophils 
from IV-4 compared with control when stimulated with LPS, 
but not in response to other experimental conditions (Fig. 4 J). 
The neutrophil defects in these patients appeared relatively 
mild, as respiratory burst and phagocytosis were normal (Table 
S1). We further assessed neutrophil migratory function from 
patient IV-4 using a modified Dunn chamber, and found no 
significant difference in velocity or chemotactic index (Fig. 5, 
A–C). Thus, alteration in neutrophil function alone is unlikely 
to account for the full disease phenotype. Although neutrophil 
chemotaxis was reduced, the presence of functional immuno-
deficiency was not fully evaluated in the WDR1rd/rd mouse, 
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as mice were kept in a relatively protected environment (Kile 
et al., 2007; Kim et al., 2015). The ability of moDCs from pa-
tient IV-4 to phagocytose and process uncapsulated Neisseria 
meningitidis (an actin-mediated process; Jones et al., 2008) 
was reduced (Fig. 5 D), suggesting that the phagocytic defect 
may not affect all phagocytic cell types to the same extent, and 
may reflect a defect in the subsequent processing of antigen for 
presentation in DCs (Savina and Amigorena, 2007).
Immunodeficiency in these patients is likely to be mul-
tifactorial, given the manifold roles that podosomes and actin 
play in the immune system. Similar to Wiskott-Aldrich syn-
drome, we observed a diminished T cell proliferative response 
to aCD3 stimulation, but intact PHA response (Dupré et 
al., 2002; Sasahara et al., 2002; Bouma et al., 2011; Calvez et 
al., 2011; Malinova et al., 2016). This may not be surprising, 
given the importance of force generation for T cell activa-
tion, and thus expected involvement of the actin cytoskele-
ton (Hu and Butte, 2016).
Given that IL-18 activation in the WDR1rd/rd mouse 
is dependent on the pyrin inflammasome (Kim et al., 2015), 
we hypothesize that pyrin also interacts with WDR1 through 
its CARD domain. Murine caspase 11 (equivalent to human 
caspases 4 and 5) expression is induced by LPS and then binds 
WDR1 to recruit cofilin and trigger F-actin depolymeriza-
tion through a CARD domain (Li et al., 2007). Caspases 4, 5 
and 11 can be activated by binding LPS directly, again through 
the CARD domains (Hagar et al., 2013; Shi et al., 2014). Pyrin 
and the ASC complex have previously been reported to di-
rectly interact with polymerized actin (Waite et al., 2009), and 
pyrin detects the Rho GTPase, modifying activity of bacterial 
toxins through downstream changes in the actin cytoskeleton 
and subsequently activates the pyrin inflammasome (Flanna-
Figure 2. Protein structure of Wdr1 and 
predicted effect of l293F mutation. The 
WDR1 pdb file was downloaded from exPASY, 
and protein was viewed and manipulated with 
the Swiss PDB viewer. (A) The protein chain is 
colored from blue at the initiation of the N 
terminus of the protein to red. The two pro-
pellers are labeled N and C, and the blades are 
numbered 1–14. (B) A close up of the N-ter-
minal propeller showing the leucine residue 
side chain in red in blade 7, close to blade 1; 
and (C) the residue mutated to phenylalanine. 
Predicted H bonds with neighboring residues 
are shown (D) for leucine and (E) for phenyl-
alanine. The L293F amino acid change occurs 
in blade 7 close to the tail of the N-terminal 
propeller, where the protein strand feeds into 
the join with the C-terminal propeller. Hy-
drophobic interactions between blade 1 and 
7 are important for closing the circular pro-
peller structure of this domain (Mohri et al., 
2004). Each propeller blade is composed of 
four anti-parallel β-sheets; in the wild-type 
protein, the leucine residue at position 293 is 
predicted to form three hydrogen bonds sup-
porting this structure (D). Mutating this res-
idue to a phenylalanine disrupts these bonds 
(E), with predicted functional consequences, 
as the two propellers mediate protein–protein 
interactions. Residues in the N terminus are 
important for F-actin binding and disassembly 
(Mohri et al., 2004), whereas the C terminus 
interacts with the CARD domain of murine 
caspase-11 (a homologue of human caspases 
4 and 5; Li et al., 2007).
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gan et al., 2012; Gavrilin et al., 2012; Rosales-Reyes et al., 
2012; Xu et al., 2014). We speculate that WDR1 protein may 
be part of the link between these events. To begin to assess 
this, we cloned WDR1 mRNA from IV-4 or a healthy con-
trol into a pmCherry-N1 vector and transfected HEK293T 
cells. Although WT-WDR1-mCherry exhibited a uniform 
distribution, the L293F-WDR1-mCherry formed abnormal 
intense aggregates (Fig.  3 D) similar to those we observed 
in the patient moDCs (Fig.3B). We then studied co-localiza-
tion of mutant or WT WDR1 with pyrin by co-transfection 
with pyrin-GFP. When introduced in the presence of L293F-
WDR1-mCherry, we confirmed that pyrin co-localized with 
mutant WDR1 aggregates (Fig. 3 E). We speculate that this 
interaction may trigger spontaneous ASC speck formation, 
Figure 3. F-actin levels and Wdr1 expression in patient 
and HeK293t cells. (A) Representative phalloidin staining 
of polymerized F-actin of cells from patient IV-4 (blue) and 
control cells (red) using flow cytometry revealed increased 
F-actin in moDCs (n = 3), CD14− lymphocytes (n = 1), and 
immortalized lymphoblasts from patient IV-4 compared with 
control (measured three times, compared with three controls). 
(B) Confocal microscopy of moDCs from patient IV-4 and a 
healthy control stained with phalloidin (green), anti-vinculin 
(red), and anti-WDR1 (blue) revealed aberrant localization of 
WDR1 and bright staining of podosomes in cells from patient 
IV-4, performed once as patients underwent HSCT. Additional 
images are provided in Fig. S1 A. (C) Analysis of the podo-
somes with Volocity software indicated that although podo-
some number did not differ significantly between patient IV-4 
and control (P = 0.1145, two-tailed unpaired Student’s t test), 
podosome volume was significantly larger in patient IV-4 (***, 
P < 0.001; two-tailed unpaired Student’s t test; error bars rep-
resent the SEM). (D) WDR1 mRNA was cloned from patient 
IV-4 or control, fused to the mCherry reporter, and expressed 
in HEK293T cells. Mutant WDR1 produced from the patient 
mRNA formed aggregates with markedly different intracellu-
lar appearance compared with cells transfected with healthy 
control WDR1 mRNA. (E) When cotransfected with GFP-pyrin, 
the pyrin also localized to these WDR1 aggregates. Additional 
images provided in Fig. S1 B.
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Figure 4. cytokine levels in sera and in vitro stimulation of patient cells. (A) IL1β was not significantly elevated in either patient compared with sera 
from healthy pediatric controls when measured on three separate occasions over several months. (B) In contrast, IL-18 was significantly increased in both 
patients (***, P < 0.0001, two-tailed unpaired Student’s t test for both). IL-18 was also significantly elevated in the serum of sJIA patients (n = 6) compared 
with controls (**, P = 0.0023, two-tailed unpaired Student’s t test) who also showed increased levels of IL-18BP in the same samples (P = 0.0343, two-tailed 
unpaired Student’s t test), which was not observed in either patient (C). (D) In patient IV-2, IL-18 mirrored CRP and serum amyloid A (SAA) levels; but was 
persistently elevated in IV-4, even when CRP and SAA were normal (E; IL-18 measured by ELI SA). (F) Caspase-1 activation, measured as the proportion of 
FLI CA+ cells by flow cytometry was significantly elevated in CD14+ cells from both patients (n = 2) compared with controls (n = 4) and CAPS patients (n = 
5) at baseline and after stimulation with LPS and staurosporine (*, P < 0.05; **, P < 0.01, two-tailed unpaired Student’s t tests). (G) IL-1β levels produced by 
moDCs after 4 h at baseline or upon treatment with LPS showed little difference between cells from control and patient IV-4, but IL-18 levels in the same 
supernatant were much higher in patient IV-4 (H). Experiment was performed once, as patient cells were limited because this patient underwent HSCT. 
(I) In the moDCs from this same experiment, the relative amount of polymerized F-actin in these same moDCs from patient IV-4 was higher compared with 
control moDCs, and increased even further upon stimulation with LPS (error bars represent experimental replicates from reciprocal staining with CFSE). 
(J) IL-18 production from neutrophils from patient IV-4 and control at baseline and after treatment with LPS, N-formylmethionyl-leucyl-phenylalanine 
(FMLP) and TNF. LPS stimulated greater IL-18 production from neutrophils from patient IV-4 (experiment performed once, again due to limited availability 
of cells from this patient). Error bars in each panel indicate SEM. Anak, Anakinra; ATP, adenosine triphosphate Aza, azathioprine; Col, colchicine; HC, healthy 
control; IL-18 BP, IL-18–binding protein; Mepred, methylprednisolone; MFI, median fluorescence index; Pred, prednisolone; SAA, serum amyloid A.
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activating the pyrin inflammasome. We investigated heterozy-
gous family members and found no increase in polymerized 
phalloidin levels, inflammasome activation, or IL-18 produc-
tion in their cells (Fig. S2). This confirms that the phenotype 
is recessive, even if this mutation has an activating component 
it cannot manifest without complete loss of wild-type pro-
tein function. We also do not have data on the comparative 
binding kinetics of wild-type and mutated protein and how 
they interact when both are present. This warrants further 
study in the future. Because activation of the pyrin inflam-
masome culminates in caspase-1 activation, we measured this 
using the FLI CA assay and flow cytometry gating on CD14+ 
Figure 5. Migratory capacity of neutrophils and phagocytosis of uncapsulated n. meningitidis by modcs. Neutrophils isolated from patient IV-4 
and control showed no significant difference in migratory capacity in regards to instantaneous angle of migration (A), velocity (B), or chemotactic index (C). 
Experiment performed once as patients underwent HSCT. Example traces of migrating cells are shown in D. Bar, 100 µm. (E) Patient IV-4 and control moDCs 
were incubated with FITC-labeled uncapsulated N. meningitidis (FITC-nm; green). After 4 h, cells were fixed and labeled with TOPR0-3 nuclear stain (blue), 
and anti-P1.7 antibodies (red) which only labels the surface of any bacteria external to the cells, thus identifying bacteria that have not been phagocytosed. 
After 4 h, control cells had phagocytosed nearly all the FITC-nm and transported them adjacent to the nucleus, whereas fewer of the patient moDCs had 
completed this process. The mean proportion of control moDCs undergoing phagocytosis was 0.56 (SD = 0.18) versus 0.22 (SD = 0.11), performed once on 
moDCs from patient IV-4 (P = 0.04; unpaired t test).
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cells from PBMCs, and found greater caspase-1 activation 
in both patients at baseline and after stimulation compared 
with healthy controls and patients with cryopyrin-associated 
periodic syndrome (CAPS), who are known to have sponta-
neous NLRP3-inflammasome activation and high caspase-1 
(Fig. 4 F). Similar to the murine model, these results confirm 
that caspase-1 activation and elevated IL-18 are likely to be 
central to the pathogenesis of autoinflammation in humans 
caused by mutated WDR1 protein.
We observed ultrastructural abnormalities of mega-
karyocytes in patient IV-4 (Fig.  1  D), revealing occasional 
small, atypical megakaryocytes, with no nucleus and failure of 
the development of the demarcating membrane system. The 
thrombocytopenia we observed could thus be explained by 
dysfunctional platelet shedding, because WDR1 is required 
for megakaryocyte maturation and platelet shedding in the 
WDR1rd/rd mouse (Kile et al., 2007).
In conclusion, homozygous missense L153F/L293F 
mutation in the actin regulatory gene WDR1 causes a new 
AID in humans, with periodic fevers, immunodeficiency, and 
intermittent thrombocytopenia (PFIT). The human disease 
resembles the murine WDR1rd/rd mouse model caused by 
hypomorphic recessive WDR1 mutations (Kile et al., 2007; 
Kim et al., 2015), and this highlights a potentially crucial link 
between the actin cytoskeleton and autoinflammation. New 
questions now arise regarding the precise molecular mecha-
nisms governing WDR1 activity and the human PFIT phe-
notype. Although we cannot yet conclude that PFIT is driven 
purely by IL-18, our data do suggest an important role for 
this proinflammatory cytokine, driven by caspase-1 activation. 
Targeted IL-18 blockade, if available, might have been a more 
effective strategy to treat the autoinflammatory component of 
the disease. In the WDR1rd/rd mouse, transplant of bone mar-
row cells from wild-type mice corrected the autoinflammatory 
phenotype and macrothrombocytopenia; the same appears to 
be true in PFIT, as allogeneic HSCT cured patient IV-4. Given 
that severe autoinflammation coexists with immunodeficiency 
and thrombocytopenia in PFIT, for the time being, we suggest 
that HSCT is the most appropriate treatment.
MaterIals and MetHods
experiments
This study was approved by the Bloomsbury ethics committee 
(ethics number 08H071382); we obtained written informed 
consent from all the family members and controls who par-
ticipated. In vitro studies were performed in CD14+ moDCs, 
CD14− lymphocytes, neutrophils, and EBV immortalized B 
cells from patients and controls. Confocal microscopy was 
performed in HEK293T cells transfected with WDR1 cloned 
from the mRNA of patient IV-4 or of a healthy WT control, 
and fused to the mCherry reporter; and with GFP-pyrin. 
Granule release assay
The granule release assay was performed according to 
Wheeler et al. (2010). PBMCs were stimulated with IL-2 
overnight, and then incubated with FITC-conjugated anti- 
CD107a antibody alone, or with anti-CD3 antibody or PHA, 
for 2 h. Samples were analyzed by flow cytometry and gating 
on lymphocytes by forward/side scatter. CD107a expression 
was analyzed on cytotoxic T cells (CD8+ and CD3+) and on 
NK cells (CD56+ and CD3−), and the increase in percent-
age of CD107a+ cells between unstimulated and stimulated 
samples was calculated.
PHa and cd3 stimulation
PHa stimulation. Whole blood was stimulated with PHA (In-
verness Medical), which preferentially stimulates T helper 
(CD4) cells via the IL-2 receptor, to assess an immune re-
sponse. The blood was diluted 1:20 with RPMI-1640 (Life 
Technologies). 200 µl of cell suspension was pipetted into 10 
wells. The first two wells were untreated; the remaining eight 
wells had PHA added to duplicate wells in concentrations of 
1, 2, 4, and 8 µg/ml. The plate was incubated at 37°C 
with 5% CO2 for 4 or 3 d.
cd3 stimulation. Lymphocytes were separated from whole 
blood using lymphoprep (Alere), and the cells were then cul-
tured at a concentration of 106/ml with 10% AB serum in 
RPMI with and without anti-CD3 at a final concentration of 
0.3 µg/ml (eBioscience) in triplicate, then incubated at 
37°C with 5% CO2 for 4 d.
For both assays to measure the proliferation, 10  µl (1 
μCur) of tritiated thymidine (PerkinElmer) was added to 
each of the wells, and the plate was returned to the incubator 
for 4 h. Any actively dividing cells incorporated the tritiated 
thymidine. The plates were then harvested (FilterMate cell 
harvester; PerkinElmer) and the radioactivity was counted 
using the β counter (TopCount β counter; PerkinElmer). The 
amount of proliferation was demonstrated by the amount of 
tritiated thymidine incorporation into the cells measured by 
CPM on the β counter. Control samples were always set up 
alongside patient samples. For PHA stimulation, control results 
should be <400 CPM for 0 µg/ml PHA and >12,500 for the 
highest CPM. For CD3 stimulation, control results should be 
<600 CPM without anti-CD3 and >6,000 with anti-CD3.
neutrophil phagocytosis assay
Neutrophil phagocytosis at 2, 5, and 10 min was analyzed 
in whole blood using the Glycotope Phagoburst Assay (BD) 
according to the manufacturer’s instructions. A normal range 
was established using 50 healthy individuals, and a normal 
control was run with each sample.
electron microscopy of bone marrow aspirate
EDTA bone marrow samples were centrifuged to form 
buffy coat preparations. These were fixed in 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer, followed by secondary 
fixation in 1.0% osmium tetroxide. Samples were dehydrated 
in graded ethanol, transferred to propylene oxide, and then 
infiltrated and embedded in Agar 100 epoxy resin. Polym-
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erization was at 60°C for 48  h. 90-nm ultrathin sections 
were cut using a Diatome diamond knife on a Leica Ul-
tracut UCT ultramicrotome. Sections were picked up on 
copper grids and stained with alcoholic uranyl acetate and 
lead citrate. The samples were examined in a JEOL 1400 
transmission electron microscope and images recorded using 
an AMT XR80 digital camera.
Genetic mapping and sequencing
200 ng genomic DNA from patients, siblings, and the parents 
was isothermally amplified and enzymatically fragmented 
before hybridization to Illumina Human610-Quad arrays 
overnight. These were imaged using the Illumina iScan. The 
regions of homozygosity were identified using Illumina’s 
Beadstudio with the Loss of heterozygosity detector plug-in 
(version 1.0.3); the minimum number of contiguous homo-
zygous SNPs was set to 100.
Whole-exome sequencing was completed using the 
TruSeq exome kit (version 2; Illumina) and sequenced on the 
HiSeq2000 (Illumina). The raw sequence data were aligned 
to the human reference genome using the Burrows-Wheeler 
Aligner (BWA) alignment algorithm. Variant calling was with 
the Genome Analysis ToolKit (GATK). Variant annotation 
was with ANN OVAR and SNP EFF.
The WDR1 variant was confirmed and familial seg-
regation ascertained by PCR and Sanger sequencing using 
the following primers to amplify and sequence exon 8 for-
ward: 5′-ACT CTG GTC TCT TCC CTG TCC-3′ and re-
verse: 5′-TTT GGG GTC TCT CTC CAG TC-3′. Sequencing 
was completed with the AB3730 using the BigDye v3.1 
kit (Applied Biosystems).
The WDR1 pdb file was downloaded from ex-
PASY, and protein was viewed and manipulated with 
Swiss PDB viewer.
PBMc and neutrophil separation
Blood was collected into Falcon tubes (Thermo Fisher 
Scientific) containing 35 U preservative-free heparin (CP 
Pharmaceuticals) per 50  ml. 2  ml of a 5% dextran-saline 
solution was added per 10  ml of blood and gently mixed 
by inversion before being left to sediment for 30 min. The 
plasma layer was collected and overlaid on an equal vol-
ume of Ficoll-Paque reagent, and then centrifuged 800  g 
for 10 min with the brake off. The PBMC layer was taken 
for CD14+ cell selection, and the neutrophil pellet was re-
suspended in distilled water for 20 s before addition of 2× 
saline solution to restore isotonicity. The neutrophils were 
then centrifuged at 1,200 rpm for 7 min and resuspended in 
warm RPMI with 10% FCS.
Monocyte and lymphocyte separation
CD14+ cells were magnetically labeled and positively selected 
on LS columns (Miltenyi Biotec). The CD14− lymphoctyes 
were collected in column flow-through. CD14+ cells were 
eluted from the column for moDC generation.
modc generation
CD14+ cells were cultured in the presence of 10 ng/ml re-
combinant human IL-4 (rhIL-4) and 10 ng/ml recombinant 
human granulocyte-macrophage colony stimulating factor 
for 6 d. Cells were split on days 2 and 5, with addition of fresh 
cytokines. On day 6 or 7, both adherent and suspension cells 
were harvested for use.
B-lymphoblastoid cell lines (B-lcl) generation
EBV viral supernatant was produced from the B95-8 cell line, 
which releases high titers of transforming EBV. This virus was 
then used to establish human lymphoblastoid lines. In brief, 
on day 0, 2.5 × 107 B95-8 cells were suspended in 15 ml 
(1.67 × 106/ml) of RF10 (RPMI 1640 + 10% FCS and pen/
strep) and added to the small compartment of a CL 1000 
flask (CELLine). The nutrient compartment was filled with 
1 liter of nutrient medium (RPMI 1640; 5% FCS and pen/
strep). After incubation for 1 wk at 37°C, cells were harvested, 
spun at 400 g for 5 min, and the supernatant was removed, 
before being resuspended in 15 ml RF10 and returned to the 
cell compartment after the removal of the nutrient medium. 
This was replaced with 1 liter of RPMI and pen/strep, and no 
serum was added to encourage the virus release.
On day 16, the cells were harvested and spun at 450 g 
for 20 min. The supernatant was collected and was spun again 
at 450 g for 20 min. The supernatant was then passed through 
a 0.45-µm filter and stored at –80°C.
5 × 106 PBMCs were pelleted and 200 µl of EBV viral 
supernatant was added, followed by 1.8 ml of RF10 with 1 
µg/ml of ciclosporin to prevent cytotoxic T cell killing. 5 × 
105 cells (200 µl) were cultured in five wells of a 96-well plate. 
An additional 1 ml of RF10 with ciclosporin was added to the 
remaining cells, and 200 µl was plated in 10 more wells. After 7 
d, 100 µl of medium in each well was replaced with fresh RF10. 
The culture was monitored and the medium replaced once it 
had turned yellow, until the point was reached where this was 
required every day and large cell clumps could be clearly seen. 
Then three wells were combined into one well of a 24-well 
plate with 1.4 ml of RF10. Again, these were expanded until 
the media needed to be replaced daily, and then transferred to 
a T25 with 5 ml RF10 and 100 µM acyclovir to kill any re-
maining virus. RF10 and acyclovir was added every 4–5 d and 
after 1–2 wk, transferred to a T75. These were split every 4–5 d.
F-actin quantification by flow cytometry
Flow cytometry of F-actin was performed in moDCs; 
CD14-negative lymphocytes; and B-LCLs from patient IV-4, 
and healthy controls. Patient and control cells were stained 
concurrently to control for any potential differences aris-
ing during the staining process. One population was labeled 
with a cell tracker (carboxyfluorescein succinimidyl ester 
[CFSE] or Dichloro-Dimethylacridin-2-One succinimidyl 
ester [DDAO-SE]; Molecular Probes) for 15 min in RPMI at 
37°C, whereas the other was incubated in RPMI alone. This 
was performed reciprocally. Cells were fixed in 4% PFA for 
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20 min, during which time the populations were mixed, then 
permeabilized with 0.1% Triton X-100 for 5 min. Cells were 
incubated with phalloidin conjugated to Alexa Fluor-488 
(DDAO) or Alexa Fluor-647 (CFSE; Molecular Probes) di-
luted 1/200 in PBS for 45 min and analyzed using the CyAn 
ADP Analyzer (Beckman Coulter).
confocal microscopy of modcs
100,000 moDCs were seeded onto coverslips coated in poly 
L-lysine and allowed to settle for 45 min. These were fixed 
with 4% PFA for 20 min, and then permeabilized with 0.5% 
triton X for 5 min. After this, nonspecific binding was blocked 
with donkey serum for 1 h. Coverslips were then incubated 
with goat anti-WDR1 (Santa Cruz Biotechnology) and rab-
bit anti-vinculin (Abcam) for 45 min, and, subsequently, Alexa 
Fluor-568 anti-rabbit and Alexa Fluor-647 anti–goat sec-
ondaries plus phalloidin-488 (Life Technologies). These were 
mounted with aquapolymount and imaged using the LSM 710 
confocal microscope (ZEI SS) with 63× objective (Plan-Apo-
chromat; numerical aperture, 1.4; working distance, 190 µm; 
imaging medium, oil) with Zen2009 software (ZEI SS).
Wdr1 mrna cloning
RNA was extracted from control and patient IV-4 B-LCL 
using TRIzol (Invitrogen) as per the manufacturer’s instruc-
tions, and reverse transcribed with the high-capacity RNA to 
cDNA kit (Applied Biosystems). WDR1 transcript was PCR 
amplified, and restriction sites were added using Phusion high 
fidelity polymerase (NEB), and the following primers: for-
ward (XhoI) 5′-CGC TCG AGA TGC CGT ACG AGA TCA 
AG-3′; and reverse (BamHI) 5′-CCG GAT CCT CTG AGG 
TGA TTG TCC-3′. The resultant PCR product was digested 
with FastDigest BamHI and XhoI (Thermo Fisher Scientific) 
for 15 min at 37°C. The pmCherry-N1 plasmid was also di-
gested with BamHI and XhoI. The digests were size-selected 
on a 0.7% TAE agarose gel and purified using the minelute 
gel extraction kit (QIA GEN). 50 ng of plasmid was annealed 
with 60 ng PCR insert (a molar ratio of 1:3) using T4 DNA 
ligase (NEB). This was transformed into TOP10 (Invitrogen) 
chemically competent E. coli as per the manufacturer’s in-
structions and plated onto Luria Broth (LB) plates containing 
100 µg/ml ampicillin (Sigma-Aldrich) and grown at 37°C 
overnight. Six colonies of control and patient sequence were 
grown overnight in 5 ml of LB containing ampicillin, and the 
plasmid was purified using QIAprep spin miniprep kit (QIA 
GEN), as per the manufacturer’s instructions. One plasmid 
containing wild-type WDR1 sequence and one plasmid con-
taining the WDR1 sequence from patient IV-4 were selected 
for sequencing and grown in large culture for maxiprep using 
the GenElute HP maxiprep kit (Sigma-Aldrich). Each of 
these were transfected into HEK293T cells.
reverse transfection of HeK293t cells
1 µg of the relevant WDR1-containing plasmid was added 
per transfection to 50 µl of opti-MEM (Gibco) and 3 µl of 
FuGENE HD (Promega), and incubated for 10 min before 
dispensing into a 24-well plate. 100,000 HEK293T cells in 
500  µl RPMI with 10% FCS were then added and incu-
bated for 24 h before imaging with a fluorescent microscope. 
For the double transfection, 1 µg of GFP-tagged pyrin in 
the pCMV6-AC-GFP vector (OriGene) was included in 
the transfection. The cells were seeded on polylysine-coated 
coverslips, and, after 24 h, were fixed with 4% PFA for 20 
min and mounted with DAPI containing anti-fade mount-
ing medium (VEC TAS HIE LD). Z-stacks through cells were 
imaged using the LSM 710 (ZEI SS) confocal microscope 
as described for moDCs.
Measurement of cytokines
IL-1β and IL-18 cytokine levels were measured in the serum 
of patients and controls, and in supernatants of in vitro exper-
iments using the ready-set-go human IL-1β ELI SA kit (eBio-
science), and IL-18 instant ELI SA kit (eBioscience) as per the 
manufacturer’s instructions. IL-18 was also measured using a 
Meso Scale Discovery (MSD) multiplex kit (Meso Scale Di-
agnostics), as per the manufacturer’s instructions in patients, 
controls, and sJIA patients. IL-18BP was measured using ELI 
SA (R&D Systems) following the manufacturer’s method. 
Control sera was obtained from healthy pediatric controls ob-
tained for the development of diagnostic tests for primary im-
munodeficiency (REC reference 06/Q0508/16; n = 22; 13 
males; median age, 5 yr; range, 0.3–16 yr). Sera was obtained 
from six sJIA patients (n = 6; three males; median age, 11.5 
yr; range, 6–15 yr; two with active disease, all on treatment).
caspase-1 activity
PBMCs were obtained from patients CAPS (n = 5; three 
males; median age, 3 yr; range, 2.5–7.3 yr; 1 with chronic in-
fantile neurological and cutaneous (CIN CA) syndrome; and 
4 with Muckle Wells Syndrome; CAPS disease activity score 
median 1/20, range 0–4/20; all treated with canakinumab); 
and from four healthy adult controls.
PBMCs were seeded in a 96-well plate at a density 
of 1.6 × 105 cells/well (8.0 × 105 cells/ml). Relevant wells 
were primed with 100 ng/ml LPS for 4 h, and, if required, 
then stimulated with 5 mM ATP for 30 min. Additional wells 
were treated with 2  µM staurosporine for 4  h as positive 
control. Caspase-1 activity was measured using FLI CA (Im-
munoChemistry Technologies), a cell-permeable fluorescent 
probe (FAM-YVAD-FMK) that binds active caspase-1. Cells 
were incubated for 1 h with FLI CA at 37°C and stained with 
PE-conjugated anti-CD14 (BD) to identify monocytes. The 
gating strategy consisted of including live CD14+ cells, which 
were subsequently analyzed for the frequency of FLI CA+ cells.
dc phagocytosis assay
moDCs were resuspended at 5 × 105/ml in RPMI and 
10% FCS. moDCs (100 µl) were then co-cultured with an 
FITC-labeled unencapsulated mutant of N. meningitidis 
H44/76 (siaD), at a multiplicity of infection of 100. Cells 
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were then incubated for 4 h at 37°C, and then harvested after 
a series of PBS washes. The residual cell pellet was vortexed, 
and 20 µl was spotted onto adhesion slides (VWR) and left 
for 10 min to adhere, washed with PBS, and fixed for 10 
min in 4% PFA. Slides were stored at −20°C until staining 
with 10 mg/ml P1.7 antibodies specific for N. meningitidis 
H44/76 (NIB SC), followed by Alexa Fluor 568 goat anti–
mouse IgG (Life Technologies) and TO-PRO-3 (Molecular 
Probes; Jones et al., 2007).
The proportion of moDCs that were undergoing 
phagocytosis was calculated from fields of cells containing 
at least eight nuclei. A phagocytic event was scored a FITC 
cluster near the nucleus in the absence of the red P1.7 signal.
neutrophil migration assay
Coverslips were coated with a 25 mg/ml fibrinogen for 1 h 
at 37°C, and then washed twice with PBS. 105 neutrophils 
were left to adhere to the coated coverslip for 30 min. The 
coverslip was then washed once with medium. A chemokine 
gradient was established within the Dunn chamber by filling 
the outside well with 80 µl of 1% agarose gel containing 100 
nM formyl methionyl leucyl phenylalanine chemokine and 
leaving it to polymerize for 2 min. The inner well was filled 
with 50 µl of the media without chemokine, and then the 
chamber was completed, placing the coverslip with the neu-
trophils over the top. The chamber was then sealed with wax. 
Migration was imaged at 37°C on an Axiovert 135 micro-
scope (ZEI SS) equipped with a motorized stage that captured 
one image per minute for 1 h. The movie was quantified by 
using ImageJ (National Institutes of Health) and Ibidi analysis 
software. Velocity is the mean of all the instantaneous veloc-
ities (ratio between the distance d and time t) between two 
successive time points: v = 1(n − 1) Σ ((d(pi, pi + 1))∕(Δt)) 
n − 1 i = 1. Chemotactic index (CI) is the ratio between the 
net distance (direct distance between the starting point and 
the ending point) and the total distance (sum of distances 
the cell traveled between two time points): CI = d(p1, pn) Σ 
d(n − 1 i = 1 pi ⁄, pi + 1). The instantaneous angle is the angle 
between the direction of the chemoattractant gradient and 
the direction traveled by the cell between two time points: 
αi = arc tan((yi + 1 2 yi)(xi +1 2 pi)).
shrna-mediated knock-down of Wdr1 in tHP1 cells
Six lentiviral shRNAs against WDR1 were ordered from 
Open Biosystems pGIPZ shRNAmir library through the 
UCL RNAi core. Virus was produced in HEK293T cells 
and used to transduce into the THP1 monocytic cell line, as 
previously described (Naldini et al., 1996). Stably transduced 
lines were obtained using selection with Puromycin. Knock-
down of WDR1 was validated by Western blot.
statistical analyses
All statistics (ANO VA and unpaired Student’s t tests) and 
graphs were produced using Prism version 4 (GraphPad). P > 
0.05 was considered significant.
online supplemental material
Fig. S1 provides additional examples of microscopy images 
of moDCs and transfected 293T HEK cells shown in Fig. 3. 
Fig. S2 shows the phenotype in heterozygous individuals 
and in THP1 cells with WDR1 knockdown did not differ 
from wild-type in several parameters. Table S1 elucidates in 
more detail the treatments and immunological tests received 
by the two patients. Regions of genetic homozygosity found 
in both of these patients and not in the siblings or parents 
are listed in Table S2.
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